CAS: 3131-03-1 - N-{22-[4-(dimethylamino)benzyl]-6-ethyl-10,23-dimethyl-5,8,12,15,17,21,24-heptaoxo-13-phenyldocosahydro-12H-pyrido[2,1-f]pyrrolo[2,1-l][1,4,7,10,13,16]oxapentaazacyclononadecin-9-yl}-3-hydroxypyridine-2-carboxamide
Formel:C45H54N8O10
InChl:InChI=1/C45H54N8O10/c1-6-31-42(59)52-22-11-14-32(52)43(60)51(5)34(24-27-16-18-29(19-17-27)50(3)4)44(61)53-23-20-30(54)25-33(53)39(56)49-37(28-12-8-7-9-13-28)45(62)63-26(2)36(40(57)47-31)48-41(58)38-35(55)15-10-21-46-38/h7-10,12-13,15-19,21,26,31-34,36-37,55H,6,11,14,20,22-25H2,1-5H3,(H,47,57)(H,48,58)(H,49,56)/t26?,31?,32?,33?,34-,36?,37?/m0/s1
- Synonyme:
- 2-pyridinecarboxamide, N-[22-[[4-(dimethylamino)phenyl]methyl]-6-ethyldocosahydro-10,23-dimethyl-5,8,12,15,17,21,24-heptaoxo-13-phenyl-12H-pyrido[2,1-f]pyrrolo[2,1-l][1,4,7,10,13,16]oxapentaazacyclononadecin-9-yl]-3-hydroxy-
Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
---|---|---|---|---|
Pristinamycin IA REF: 4Z-P-173001CAS: 3131-03-1 | - - - | Nachfragen | Mo 23 Dez 24 | |
Pristinamycin IA REF: 3D-FP172927CAS: 3131-03-1 | Min. 95% | Nachfragen | Mo 27 Jan 25 | |
Pristinamycin IA REF: TM-T12540CAS: 3131-03-1 | 97.92% | Nachfragen | Di 18 Feb 25 |
Ref: 4Z-P-173001
10mg | Nachfragen | ||
25mg | Nachfragen | ||
50mg | Nachfragen | ||
100mg | Nachfragen |
Pristinamycin IA
Ref: 3D-FP172927
10mg | Nachfragen | ||
25mg | Nachfragen | ||
50mg | Nachfragen | ||
100mg | Nachfragen | ||
250mg | Nachfragen |
Pristinamycin IA
Ref: TM-T12540
1mg | 99,00 € | ||
5mg | 245,00 € | ||
10mg | 394,00 € | ||
25mg | 655,00 € | ||
50mg | Nachfragen | ||
1mL*10mM (DMSO) | 375,00 € |